TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmaq Analytiq AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
7,717
|
7,480
|
8,282 |
| Financial expenses |
48
|
46
|
8 |
| Earnings before taxes |
-62
|
-606
|
-387 |
| Total assets |
3,594
|
4,777
|
5,736 |
| Current assets |
1,679
|
2,542
|
3,037 |
| Current liabilities |
1,766
|
2,755
|
3,664 |
| Equity capital |
1,808
|
1,982
|
2,031 |
| - share capital |
98
|
104
|
110 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
50.3%
|
41.5%
|
35.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-0.8%
|
-8.1%
|
-4.7% |
| Return on assets (ROA) |
-0.4%
|
-11.7%
|
-6.6% |
| Current ratio |
95.1%
|
92.3%
|
82.9% |
| Return on equity (ROE) |
-3.4%
|
-30.6%
|
-19.1% |
| Change turnover |
712
|
-367
|
2,731 |
| Change turnover % |
10%
|
-5%
|
49% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.